<records>
<record>
<language>eng</language>
<publisher>Excellent Publishers</publisher>
<journalTitle>
International Journal of Current Microbiology and Applied Sciences (IJCMAS) CODEN(USA)-IJCMO9
</journalTitle>
<issn>2319-7692</issn>
<eissn>2319-7706</eissn>
<publicationDate>2015-01-10</publicationDate>
<volume>5</volume>
<issue>1</issue>
<startPage>1</startPage>
<endPage>9</endPage>
<documentType>article</documentType>
<title language="eng">
Evaluation of Novel Immunological Mediator in Patients With
Helicobacter pylori in Baghdad City, Iraq
</title>

<authors>
<author>
<name>Thamer Mutlag Jasim</name>
<affiliationId>1</affiliationId>
</author>

</authors>
<affiliationsList>
<affiliationName affiliationId="1">
Department of Laboratory Clinical Sciences, College of Pharmacy,
All Mustansiriya University, Baghdad, Iraq
</affiliationName>

</affiliationsList>

<abstract language="eng">
<p>
Helicobacter pylori (H.pylori) infection is endemic in Iraq and important cause of
gatrointestinal disorders, as well as an increase in blood levels of certain
inflammatory markers. Sixty patients infected with H.pylori was inserted in the
current study with age (31.4±3.96) randomly selected from Al Yarmok of
Teaching Hospital in Baghdad during April 2015. Patients were diagnosed by
using stool antigen and CagAIgG. The medical history was taken, body weight and
height were measured and body mass index (BMI) was calculated. Serum
Monocyte chemoattractant protein 1 (MCP1) was determined, as well as
Interleukin 6 (IL-6) and Fetuin A levels. For comparison, thirty apparently
healthy subjects which were matched with patients group for age, weight and BMI
(n=30, age=30.5±3.77 years; BMI= 27.13± 2.13 kg/m2; mean±SD). The
prevalence of anti H.pylori Cag A-IgG antibodies in patient group (78.3±9.8 U/ml)
significantly higher(&lt;0.0001) than healthy subjects group (4.2±2.8 U/ml). H.pylori
was capable with a significant rise in the in the inflammatory mediators (fetuin A,
MCP1 and IL-6). Fetuin A levels were very highly significant lower(p&lt;0.0001) in
patient, group when compared to healthy subjects(29.53±5.25 vs 53. 45±8.37
respectively). The MCP1 levels which significantly increased(p&lt;0.0001)in patient
group(48.79±6.03) when compared to control group (37.2±6.85). The mean of IL-6
also shown highly significant difference in patient group when compared to healthy
control. The current study also shown there was a positive correlation between
MCP1 and IL-6.
</p>
</abstract>

<fullTextUrl format="pdf">
http://www.ijcmas.com/vol-5-1/Thamer%20Mutlag%20Jasim.pdf
</fullTextUrl>
<keywords language="eng">
<keyword>H.pylori</keyword>
</keywords>
<keywords language="eng">
<keyword>Cag A-IgG</keyword>
</keywords>
<keywords language="eng">
<keyword>Fetuin A</keyword>
</keywords>
<keywords language="eng">
<keyword>IL-6</keyword>
</keywords>
<keywords language="eng">
<keyword>MCP1</keyword>
</keywords>
</record>
</records>